Hepatitis C natural history: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) No edit summary |
Varun Kumar (talk | contribs) |
||
Line 15: | Line 15: | ||
*:* 80% have persistent infection | *:* 80% have persistent infection | ||
*:*:* 30% of these patients develop cirrhosis | *:*:* 30% of these patients develop cirrhosis | ||
* | * Genotype | ||
*:* Predicts response to treatment | *:* Predicts response to treatment | ||
*:* Genotype 1 less responsive than types 2 & 3 | *:* Genotype 1 less responsive than types 2 & 3 |
Revision as of 17:01, 21 February 2012
Hepatitis C |
Diagnosis |
Treatment |
Hepatitis C natural history On the Web |
American Roentgen Ray Society Images of Hepatitis C natural history |
Risk calculators and risk factors for Hepatitis C natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; Assistant Editor-In-Chief: Nina Axiotakis [3]
Natural History
Of every 100 people infected with the Hepatitis C virus, about
- 75–85 people will develop chronic Hepatitis C virus infection; of those,
- 60–70 people will go on to develop chronic liver disease
- 5–20 people will go on to develop cirrhosis over a period of 20–30 years
- 1–5 people will die from cirrhosis or liver cancer
Prognosis
- Acute Infection
- 20% recover
- 80% have persistent infection
- 30% of these patients develop cirrhosis
- Genotype
- Predicts response to treatment
- Genotype 1 less responsive than types 2 & 3